| Literature DB >> 30356694 |
Antoni Gayà1,2, Javier Calvo1,2.
Abstract
Donor human milk (DHM) in human milk banks (HMB) is routinely subjected to heat treatment to ensure microbiological security, most guidelines recommending a temperature of 62. 5°C for 30 min. However, this procedure negatively impacts on milk quality, due to the destruction of biological components. Different studies have called for a more respectful treatment of DHM to preserve its properties, and have explored the use of alternative technologies. There is also clear evidence that bacterial and viral contamination in human milk can be effectively destroyed by temperatures lower than that currently recommended (62.5°C). Thus, a simple option would be to optimize the conventional pasteurization technique so the treated milk is free of infectious elements yet retains a maximum amount of biological components. An advantage of this approach is that it would be unnecessary to replace the pasteurization equipment currently available in most HMB. On the basis of a literature review, we here analyze and discuss evidence that pasteurization of human milk at a temperature below 62.5°C results in an improved preservation of its properties without compromising safety regarding the transmission of infectious agents.Entities:
Keywords: biological components of milk; donated human milk; human milk bank; pasteurization; temperature
Year: 2018 PMID: 30356694 PMCID: PMC6189300 DOI: 10.3389/fped.2018.00288
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
Viral sensitivity to thermal treatment.
| Parvovirus B19 | 10′ at 60°C | Completely inactivated | Blümel et al. ( |
| Chikungunya virus | 30′ at 58 ± 1°C | Completely inactivated | Leydold et al. ( |
| Poliovirus | 30′ at 55°C | Completely inactivated | Strazynski et al. ( |
| West Nile virus | 30′ at 58 ± 1°C | Completely inactivated | Leydold et al. ( |
| Hepatitis C virus | 30′ 56°C | Almost completely inactivated | Song et al. ( |
| 40′ at 56°C 10′ at 60°C 4′ at 65°C | Completely inactivated | ||
| Herpes simplex virus | 20′ at 50°C | Completely inactivated | Plummer and Lewis ( |
| Human Immunodeficiency virus | less than 30′ at 60°C | Completely inactivated | Spire et al. ( |
| Human T lymphotrophic virus | 30′ at 56°C | Completely inactivated | Harada et al. ( |
| Zika virus | 30′ at 63°C | Completely inactivated | Pfaender et al. ( |
| Human papiloma virus | 30′ at 62.5°C | Completely inactivated | Donalisio et al. ( |
| Ebola virus | 30′ at 62.5°C | Completely inactivated | Hamilton Espence et al. ( |
| Margburg virus | 30′ at 62.5°C | Completely inactivated | Hamilton Espence et al. ( |
| Cytomegalovirus | 30′ at 62.5°C | Completely inactivated | Hamprecht et al. ( |
| 40′ at 50°C | Partially inactivated | Plummer and Lewis ( | |
| 30′ at 56°C | Partially inactivated | Welsh et al. ( |